Bayrak, O. Et Al. 2024. Metformin-an oral antidiabetic agent- improves chemotherapy efficacy in colorectal cancer by inhibiting hypoxia-induced metabolic adaptation. MOLECULAR ONCOLOGY , vol.18 , 431.

Bayrak, O., Kemahlı, M. B., Kasap, M. E., Başbınar, Y., & Bayrak, S., (2024). Metformin-an oral antidiabetic agent- improves chemotherapy efficacy in colorectal cancer by inhibiting hypoxia-induced metabolic adaptation. MOLECULAR ONCOLOGY , vol.18, 431.

Bayrak, Ozge Et Al. "Metformin-an oral antidiabetic agent- improves chemotherapy efficacy in colorectal cancer by inhibiting hypoxia-induced metabolic adaptation," MOLECULAR ONCOLOGY , vol.18, 431, 2024

Bayrak, Ozge Et Al. "Metformin-an oral antidiabetic agent- improves chemotherapy efficacy in colorectal cancer by inhibiting hypoxia-induced metabolic adaptation." MOLECULAR ONCOLOGY , vol.18, pp.431, 2024

Bayrak, O. Et Al. (2024) . "Metformin-an oral antidiabetic agent- improves chemotherapy efficacy in colorectal cancer by inhibiting hypoxia-induced metabolic adaptation." MOLECULAR ONCOLOGY , vol.18, p.431.

@article{article, author={Ozge Bayrak Et Al. }, title={Metformin-an oral antidiabetic agent- improves chemotherapy efficacy in colorectal cancer by inhibiting hypoxia-induced metabolic adaptation}, journal={MOLECULAR ONCOLOGY}, year=2024, pages={431} }